Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Exclusion Criteria

• •Patients with endocrine disease
• •Hormone therapy users or those who had been pregnant in the last 12 months before the diagnosis
• •Patients with a negative expression for estrogen and/or progesterone receptors
• •Women with a history of thromboembolism
• •Patients who had previously undergone any treatment for breast cancer